ESC Premium Access

TAVI: a new standard for aortic valve replacement?

Event: ESC CONGRESS 2017
Topic: Aortic valve disease
Session type: Advances in Science
Date: 28 August 2017
Time: 14:00 - 15:30

Congress Session

5 presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)

Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Speaker: Professor E. Durand (Rouen, FR)

Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Speaker: Doctor B. Alushi (Augsburg, DE)

TAVI complications: incidence, trends and management.

Speaker: Doctor A. Chieffo (Milan, IT)

5 speakers from this session

Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)
19 presentations

Professor Eric Durand

University Hospital of Rouen, Rouen (France)
1 presentation
0 follower

Doctor Ulrich Fischer-Rasokat

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)
0 follower

Doctor Brunilda Alushi

Klinik Vincentinum, Augsburg (Germany)
0 follower

Doctor Alaide Chieffo

IRCCS San Raffaele Hospital, Milan (Italy)
17 presentations

This platform is supported by

logo Novo Nordisk